Metrics as of 10/15/2026, 06:50 PM (Berlin time), refresh in progress.
Compugen Stock
Compugen Ltd.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Israel
- CEO
- Eran Ophir
- Employees
- 75
- Market cap
- $198 M
- IPO
- 11/08/2000
- Web
- cgen.com
Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe. The company’s core activities…
Compugen stock: price history
1D
+4.8%
1W
-1.2%
1M
-13.1%
6M
-27.5%
YTD
+36.9%
1Y
+1.7%
2Y
+28.5%
5Y
-67.1%
10Y
-65.5%
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~35% stronger price swings than usual
Ask the agents about Compugen
Analyst assessment of Compugen
PRICE TARGET LOW
US$5.00
CONSENSUS
US$5.00
MEDIAN
US$5.00
PRICE TARGET HIGH
US$5.00
0
STRONG BUY
14
BUY
0
HOLD
1
SELL
0
STRONG SELL
15
TOTAL · Buy
As of: 12/10/2026
Compugen stock metrics
P/E
5.58
P/B
2.23
EV/EBITDA
5.42
RETURN ON EQUITY
-7.9%
NET MARGIN
-269.3%
DEBT/EQUITY
0.03
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.6%
FLOAT SHARES
94,373,997
AVG. DAILY VOLUME (30D)
182,170
Insider transactions (SEC)
Levine Zurit
Halevy Gilead
Hukkelhoven Mathias
Livnat Savitzky Kinneret
Kredo Russo Sharon
Institutional holders
Comparable stocks
Frequently asked questions about Compugen stock
What does Compugen do?
Compugen Ltd. is a company in the Healthcare sector, Biotechnology industry, headquartered in Israel.
The CEO is Eran Ophir, the company employs around 75 people.
The IPO was on 11/08/2000; the stock trades on NASDAQ under the ticker CGEN.
What do analysts say about Compugen stock?
15 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$5.00, ranging from US$5.00 to US$5.00, with a median of US$5.00.
This is an external assessment, not a statement by Market Jury.
When does Compugen report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 35% stronger than usual.
Does Compugen pay a dividend?
No, Compugen currently does not pay a dividend.
Which stocks are comparable to Compugen?
Comparable stocks include Alpha Tau Medical, Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines and Incyte.
How can I get Compugen stock analyzed?
Clicking "Analyze stock" lets five strategies assess Compugen against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.